V028-1162 Screening compound: 3-(2-chloro-6-methylpyridin-3-yl)-3-(5-methoxy-1H-indol-3-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide

V028-1162 Screening compound: 3-(2-chloro-6-methylpyridin-3-yl)-3-(5-methoxy-1H-indol-3-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide
V028-1162 Screening compound: 3-(2-chloro-6-methylpyridin-3-yl)-3-(5-methoxy-1H-indol-3-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V028-1162
3-(2-chloro-6-methylpyridin-3-yl)-3-(5-methoxy-1H-indol-3-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V028-1162

Molecular Formula

C24H29ClN4O3 (C24 H29 ClN4 O3)

Compound Name

3-(2-chloro-6-methylpyridin-3-yl)-3-(5-methoxy-1H-indol-3-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide

IUPAC name

3-(2-chloro-6-methylpyridin-3-yl)-3-(5-methoxy-1H-indol-3-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide

SMILES

Cc1ccc(C(CC(NCCN2CCOCC2)=O)c2c[nH]c(cc3)c2cc3OC)c(Cl)n1

InChI

InChI=1S/C24H29ClN4O3/c1-16-3-5-18(24(25)28-16)19(14-23(30)26-7-8-29-9-11-32-12-10-29)21-15-27-22-6-4-17(31-2)13-20(21)22/h3-6,13,15,19,27H,7-12,14H2,1-2H3,(H,26,30)/t19-/m1/s1

InChI Key

TYJUEJZYQXGXER-LJQANCHMSA-N

MDL Number (MFCD)

MFCD20493020

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

456.97

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.925

Distribution Coefficient, logD

2.849

Water Solubility, LogSw

-3.53

Polar Surface Area

62.374

Acid Dissociation Constant (pKa)

12.92

Base Dissociation Constant (pKb)

6.68

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

41.70

V028-1162 in Drug Discovery

Included in Screening Libraries

Indole Derivatives (10091 compounds)

PI3K-Targeted Library (17255 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Structure:
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V028-1162 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V028-1162?
Check Price and Availability of V028-1162, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V028-1162 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V028-1162
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V028-1162
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V028-1162 available by request